(HealthDay)—Patients with anxiety disorder, depression, and bulimia nervosa who drink alcohol are likely to exceed recommended limits, according to a study published online Nov. 5 in Alcoholism: Clinical & Experimental Research.
Vanessa A. Palzes, M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues assessed unhealthy alcohol use among individuals with psychiatric disorders in primary care using electronic medical record data from 2,720,231 adult primary care patients (53 percent female; 48 percent White; mean age, 46 years) screened for unhealthy alcohol use between 2014 and 2017.
The researchers found that patients with psychiatric disorders (except eating disorders) had lower odds of reporting low-risk and unhealthy alcohol use versus no use. There were 861,427 patients reporting any alcohol use, and among these patients, those with depression and anxiety disorder had higher odds of exceeding only weekly limits and both daily and weekly limits, respectively. Patients with bulimia nervosa were also more likely to exceed both daily and weekly alcohol limits.
“Health systems and clinicians may wish to consider implementing more robust screening, assessment, and intervention approaches to support these vulnerable subgroups in limiting their drinking,” the authors write.
Excessive drinking seen in some patients with chronic conditions
Copyright © 2020 HealthDay. All rights reserved.
Unhealthy drinking habits seen with some psychiatric disorders (2020, November 9)
retrieved 9 November 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022